-Advertisement-
-Advertisement-
Thyroid Eye Disease

Teprotumumab shows promise in treating dysthyroid optic neuropathy
Teprotumumab has demonstrated significant effectiveness in treating dysthyroid optic neuropathy (DON) in patients with active thyroid eye disease (TED), according to a study. The study, which reviewed 10 observational studies and case reports, supplemented by 2 cases from the authors' clinical practice, found that teprotumumab led to substantial improvements in...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-

Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved